Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 959 of 5804
-
Could a simple amino acid ease rare brain disorders?
Symptom relief Not yet recruitingA pivotal, randomized, double-blind, placebo-controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of CACNA1A. The objective of this study is to evaluate the safety, tolerability and efficacy of N-acetyl-L-leucine (IB1001) compared to …
Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can pharmacy training boost HPV shots and prevent future cancers?
Prevention Not yet recruitingThis clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for human papillomavirus (HPV) and other vaccinations in pharmacies. Low HPV vaccinati…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
New radiation technique may spare spine patients from surgery
Disease control Not yet recruitingThe main purpose of this study is to see if treating cancer with the magnetic resonance imaging guided adaptive radiotherapy (MRIdian) can control patient's tumor and eliminate the need for surgery used to treat nerves in the spine flattened by pressure (compressed).
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New brain zaps aim to unfreeze Parkinson's gait
Symptom relief Not yet recruitingParkinson disease (PD) is a common disorder in which reduced speed of movement results from inadequate brain production of the chemical dopamine. The most effective treatment for Parkinson disease is the use of drugs that provide dopamine replacement therapy (DRT). However, as th…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New scan and urine test could revolutionize bladder cancer staging
Diagnosis Not yet recruitingThe study will be a prospective two arms diagnostic phase II single-center trial. Patients referred for diagnosis and treatment with diagnosis of bladder cancer, age \> 18 years, ECOG performance status \< 2, ability to undergo an imaging study procedure will be considered for i…
Phase: PHASE2 • Sponsor: Chiti Arturo • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Could 100 hours of speech therapy transform life after stroke?
Symptom relief Not yet recruitingResearch question Does participation in an Intensive Comprehensive Aphasia Programme produce a meaningful change in the communication of people with aphasia, their quality of life and that of their carers? Background Aphasia is a persistent language disorder that severely impair…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could engineered immune cells tame type 1 diabetes?
Disease control Not yet recruitingType 1 diabetes (T1D) is a persistent and gradually increasing genetic autoimmune disease requiring life-long management. The disease commonly impacts children. However, a quarter of cases are diagnosed in adults. The pancreatic islet beta-cells are responsible for producing insu…
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a simple supplement ease a rare lung disease?
Disease control Not yet recruitingBased on existing literature and clinical trials, 2- hydroxbenzylamine (2-HOBA) has clear impact on mechanisms that much of the international field of pulmonary hypertension (PH) research agrees are central to disease progression. The investigator's preliminary data and Phase I s…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a common heart drug stop PTSD before it starts?
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate the effect of early propranolol administration on the occurrence of post-traumatic stress disorder (PTSD) symptoms at five weeks in adult female victims of sexual violence. The investigators hypothesize that propranolol administrati…
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
Eye exams could end guesswork in depression treatment
Knowledge-focused Not yet recruitingMajor depressive disorder (MDD) is a frequent and particularly disabling disorder. The efficacy of current antidepressants is limited, with 50-60% of patients not achieving a sufficient response to treatment. Indeed, to date, clinicians are unable to predict the therapeutic respo…
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
One blood transfusion could prevent ventilator setbacks in ICU
Disease control Not yet recruitingIn comparison with a liberal transfusion strategy (high haemoglobin threshold), a restrictive transfusion strategy leads to around 50% decrease in the total number of transfused red blood cells (RBC) units and 30% to 40% fewer transfused patients, without any difference in mortal…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New CBT program aims to curb youth suicide in mexico city
Symptom relief Not yet recruitingThis NIMH R34 award application proposes to conduct an adaptation, implementation, and pilot testing of the culturally centered CBT protocol, the Socio-Cognitive Behavioral Therapy for Suicidal Behaviors (SCBTSB), among suicidal youth in Mexico City, Mexico. The research plan wi…
Phase: NA • Sponsor: Bradley Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Engineered immune cells take on stomach cancer in early trial
Disease control Not yet recruitingThe goal of this clinical research study is to study the recommended dose of TROP2 CAR/IL-15 TGFBR2 KO NK cells that can be given intraperitoneally (infused directly into the stomach area) to participants with adenocarcinoma of the stomach that has spread to the peritoneum. The s…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New implant aims to ease stubborn back pain
Disease control Not yet recruitingThe purpose of this study is to evaluate outcomes in patients treated with iFuse INTRA Ti for chronic SI joint pain.
Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could Neighbor-to-Neighbor first aid save lives in cameroon?
Knowledge-focused Not yet recruitingCameroon experiences a high burden of injury-related morbidity and mortality and currently lacks a formal pre-hospital care system. Lay First Responder (LFR) programs have been implemented in several low-and middle-income countries to improve early injury care by training non-med…
Phase: NA • Sponsor: Sabrinah Christie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat myeloma
Disease control Not yet recruitingThe goal of this study is to evaluate the safety of a new type of CAR T-cell, UF-KURE-BCMA, for the treatment of patients with advanced multiple myeloma that has not responded to other therapies. The main question is whether the use of these new CAR T-cells is safe for patients w…
Phase: PHASE1 • Sponsor: Kure Cells, INC • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple silver liquid stop Kids' tooth decay without drilling?
Disease control Not yet recruitingThis is a community-based, parallel-group, double-blinded randomised controlled trial aimed at evaluating the effectiveness of single and dual applications of 38% Silver Fluoride (SF) in arresting dentinal caries among Malaysian preschool children aged 4 to 6 years. The main que…
Phase: PHASE3 • Sponsor: University of Malaya • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Timing of bowel irrigation could ease life after rectal cancer surgery
Symptom relief Not yet recruitingThis study aims to evaluate the optimal timing of trans-anal irrigation (TAI) for participants with low anterior resection syndrome (LARS) who have undergone surgery for rectal cancer. The main question it aims to answer is: "Can starting TAI within three months of stoma closur…
Phase: NA • Sponsor: Simona Ascanelli • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Custom 3D-Printed stents could spare kids with brain cancer from painful mouth sores
Symptom relief Not yet recruitingBrain cancer patients undergoing radiotherapy may experience oral complications such as oral mucositis, gingival inflammation, plaque accumulation, radiation-induced caries, and reduced oral-health-related quality of life due to scatter radiation affecting oral tissues. Although…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Ultrasound and blood markers may unlock personalized treatment for rare nerve disease
Knowledge-focused Not yet recruitingChronic inflammatory demyelinating polyradiculoneuritis (CIDP) is a rare autoimmune neuropathy characterized by significant clinical and therapeutic heterogeneity. Despite the availability of effective treatments, the response to intravenous immunoglobulins remains highly variabl…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC